Annji's phase I/II positive in spinal, bulbar muscular atrophy
Annji Pharmaceutical Co. Ltd.’s rosolutamide (AJ-201, JM-17) achieved positive results in a phase I/II trial in adults with spinal and bulbar muscular atrophy (SBMA), also known as Kennedy’s disease. “SBMA is a slowly progressing neuromuscular disorder …